Skip over main navigation
  • Sign up
  • Log in
  • Basket: (0 items)
Duchenne UK
We fund more research than anyone else
    • Search for clinical trials
    • Donate
    • Twitter
    Menu
    • About Duchenne
      • What is Duchenne
      • Diagnosing Duchenne
      • Stages Of Duchenne
      • Current Treatments
      • Supporting Therapies
      • Treatments In The Pipeline
      • Understanding Clinical Trials
      • Clinical Trial Finder
    • Patient and Parent Support
      • What to do in an emergency
      • Coronavirus Resources
      • Our message for you
      • Caring for your child
      • Resources for parents
      • Free Information Days
      • Medical Care Guidelines
      • Decipha - education support
      • Patient and Parent Stories
      • Caring during the coronavirus pandemic
    • What We Do
      • Our Mission
      • Our Impact
      • Funding Research & Trials
      • Accelerating Drug Timeline
      • Community Engagement
      • DMD Care UK
      • DMD Hub
      • Project HERCULES
      • About Us
        • Meet The Team
        • President & Patrons
        • Scientific Advisory Board
        • Patient Advisory Board
        • Donor Advisory Board
        • Trustees
        • Joining Jack
        • Alex's Wish
        • Duchenne Now
      • Watch Our Film
      • Subscribe to our PODCAST
    • Support Us
      • Duchenne Dash
      • Donate a Day
      • How You Can Help
      • Why Support Us?
      • Family and Friends Funds
      • Duchenne Direct
      • Fundraising Events
      • World's Strongest Boys
      • Corporate Support
    • News
    • Admin
      • Log in
    • Basket: (0 items)
    1. What We Do
    2. Accelerating Drug Timeline

    Accelerating Drug Development

    Duchenne UK is not only the largest funder of DMD research in the UK in the last 5 years. We are also committed to accelerating the pace of research, ensuring that we remove potential obstacles and roadblocks that lie in the path of drug development. It is vital that the research we fund has the potential to translate into clinical trials.

    So we work with industry, engage with policy makers and regulators and also fund the doctors, nurses and physiotherapists to run clinical trials. For example we funded the Phase I study of VBP15 in the US. We then co-funded Dr Guglieri at Newcastle, who will be running the VBP15 trial in the UK. We proactively invest in every stage of the drug development timeline:

    We support and encourage national and international collaboration to allow researchers and clinicians to collaborate and progress research. We are proud to support the Treat-NMD network and their bi-annual TACT meetings to review potential clinical trials for Duchenne Muscular Dystrophy.

    DMD Hub

    DMD Hub

    Expanding Clinical trial capacity Read more

    Published: 1st March, 2015

    Updated: 26th June, 2019

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Project HERCULES

    Project HERCULES

    A collaborative project to assist companies with HTA Read more

    Published: 1st April, 2015

    Updated: 8th January, 2019

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Outcome measures for DMD clinical trials

    Outcome measures for DMD clinical trials

    We work with scientists and researchers to look at how to improve the outcomes of clinical trials and ensure companies are using the right measurements to determine whether or not a drug in a clinical trial is working or not. Read more

    Published: 16th November, 2017

    Updated: 25th October, 2018

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    TREAT-NMD & TACT

    TREAT-NMD & TACT

    Treat-NMD is an international network of scientists, researchers and clinicians working in the neuromuscular field. Read more

    Published: 1st July, 2015

    Updated: 15th February, 2018

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Clinical Trial Capacity

    Clinical Trial Capacity

    We’ve invested more than £500,000 to fund vital clinical trial posts at leading centres of excellence in the UK Read more

    Published: 31st October, 2016

    Updated: 15th February, 2018

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Duchenne UK introduces the DMD Hub and newly appointed Hub Manager: Emma Heslop.

    Duchenne UK introduces the DMD Hub and newly appointed Hub Manager: Emma Heslop.

    Duchenne UK launches the DMD Hub Read more

    Published: 1st January, 2017

    Updated: 15th February, 2018

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Aparito

    Aparito

    Developing digital technology to evaluate new approaches to measuring efficacy and safety in clinical trials Read more

    Published: 24th October, 2017

    Updated: 8th November, 2017

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Engaging With Regulators

    Engaging With Regulators

    Read more

    Published: 8th March, 2016

    Updated: 26th October, 2017

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Working With Industry

    Working With Industry

    Read more

    Published: 8th March, 2016

    Updated: 26th October, 2017

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Clinical Trial Lectureship

    Clinical Trial Lectureship

    We co-funded a doctor to run clinical trials in the UK. She is now running seven trials and is the Principal Investigator on two new upcoming studies. Read more

    Published: 21st March, 2016

    Updated: 14th September, 2016

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Back to top

    Showing 10 of 10

    DMD Hub

    DMD Hub

    Expanding Clinical trial capacity Read more

    Published: 1st March, 2015

    Updated: 26th June, 2019

    Author: Nick Crossley

    Related topics:
    • Accelerating Drug Development
    Attend our FREE Information Days

    Attend our FREE Information Days

    Please join us at our free Patient Information Day Read more

    Published: 27th July, 2017

    Updated: 13th October, 2020

    Author: Nick Crossley

    Comments: 1

    Related topics:
    • Community Engagement and Support
    Impact Report 2020

    Impact Report 2020

    Despite the challenges of 2020, Duchenne UK has achieved much and we hope you find the impact report that we are releasing today, uplifting. Thank you for your support and we wish you a safe and bright 2021. Read more

    Published: 23rd December, 2020

    Updated: 27th January, 2021

    Author: Nick Crossley

    Related topics:
    • News

    Latest tweet

    Sign up for our newsletter

    Please enter your first name
    Please enter your last name
    Please enter your email address Please enter a valid email address (e.g. [email protected])

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • Youtube

    Contact UsPrivacy Policy

    Registered Charity No. 1147094. © 2020 Duchenne UK. All rights reserved.
    A non profit company limited by guarantee. Registered in England No. 8030768

    Our mailing address is: Duchenne UK, Unit G20, Shepherd’s Building, Charecroft Way, Hammersmith, W14 0EE


    We will always store your personal details securely. We’ll use them to provide the service that you have requested, and communicate with you in the way(s) that you have agreed to. Your data may also be used for analysis purposes, to help us provide the best service possible. For full details see our Privacy Policy or contact us on [email protected]